160 related articles for article (PubMed ID: 8031060)
1. Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine.
Gobert JM; Remington KM; Zhu YQ; North TW
Antimicrob Agents Chemother; 1994 Apr; 38(4):861-4. PubMed ID: 8031060
[TBL] [Abstract][Full Text] [Related]
2. The mutation frequency of feline immunodeficiency virus enhanced by 3'-azido-3'-deoxythymidine.
LaCasse RA; Remington KM; North TW
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):26-32. PubMed ID: 8624757
[TBL] [Abstract][Full Text] [Related]
3. Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
Remington KM; Chesebro B; Wehrly K; Pedersen NC; North TW
J Virol; 1991 Jan; 65(1):308-12. PubMed ID: 1845891
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidine.
Medlin HK; Zhu YQ; Remington KM; Phillips TR; North TW
Antimicrob Agents Chemother; 1996 Apr; 40(4):953-7. PubMed ID: 8849258
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
Palmer S; Harmenberg J; Cox S
Antimicrob Agents Chemother; 1996 May; 40(5):1285-8. PubMed ID: 8723486
[TBL] [Abstract][Full Text] [Related]
6. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
[TBL] [Abstract][Full Text] [Related]
7. Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptase.
Remington KM; Zhu YQ; Phillips TR; North TW
J Virol; 1994 Feb; 68(2):632-7. PubMed ID: 7507182
[TBL] [Abstract][Full Text] [Related]
8. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
Gu Z; Gao Q; Li X; Parniak MA; Wainberg MA
J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 drug susceptibility during zidovudine (AZT) monotherapy compared with AZT plus 2',3'-dideoxyinosine or AZT plus 2',3'-dideoxycytidine combination therapy. The protocol 34,225-02 Collaborative Group.
Larder BA; Kohli A; Bloor S; Kemp SD; Harrigan PR; Schooley RT; Lange JM; Pennington KN; St Clair MH
J Virol; 1996 Sep; 70(9):5922-9. PubMed ID: 8709213
[TBL] [Abstract][Full Text] [Related]
10. Differential antiviral activities and intracellular metabolism of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine in human cells.
Mukherji E; Au JL; Mathes LE
Antimicrob Agents Chemother; 1994 Jul; 38(7):1573-9. PubMed ID: 7526781
[TBL] [Abstract][Full Text] [Related]
11. Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1.
Gao Q; Gu Z; Salomon H; Nagai K; Parniak MA; Wainberg MA
Arch Virol; 1994; 136(1-2):111-22. PubMed ID: 8002779
[TBL] [Abstract][Full Text] [Related]
12. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
Smith RA; Remington KM; Preston BD; Schinazi RF; North TW
J Virol; 1998 Mar; 72(3):2335-40. PubMed ID: 9499094
[TBL] [Abstract][Full Text] [Related]
13. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
Tisdale M; Kemp SD; Parry NR; Larder BA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
[TBL] [Abstract][Full Text] [Related]
14. Mutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine.
Zhu YQ; Remington KM; North TW
Antimicrob Agents Chemother; 1996 Sep; 40(9):1983-7. PubMed ID: 8878567
[TBL] [Abstract][Full Text] [Related]
15. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
St Clair MH; Martin JL; Tudor-Williams G; Bach MC; Vavro CL; King DM; Kellam P; Kemp SD; Larder BA
Science; 1991 Sep; 253(5027):1557-9. PubMed ID: 1716788
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
Spector SA; Ripley D; Hsia K
Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
[TBL] [Abstract][Full Text] [Related]
17. Infectious amplification of wild-type human immunodeficiency virus from patients' lymphocytes and modulation by reverse transcriptase inhibitors in vitro.
Mathez D; Schinazi RF; Liotta DC; Leibowitch J
Antimicrob Agents Chemother; 1993 Oct; 37(10):2206-11. PubMed ID: 7504908
[TBL] [Abstract][Full Text] [Related]
18. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
Gao Q; Gu ZX; Parniak MA; Li XG; Wainberg MA
J Virol; 1992 Jan; 66(1):12-9. PubMed ID: 1727474
[TBL] [Abstract][Full Text] [Related]
20. Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro.
Johnson VA; Merrill DP; Videler JA; Chou TC; Byington RE; Eron JJ; D'Aquila RT; Hirsch MS
J Infect Dis; 1991 Oct; 164(4):646-55. PubMed ID: 1716649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
